thiazoles has been researched along with glucosamine in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (27.78) | 18.2507 |
| 2000's | 10 (55.56) | 29.6817 |
| 2010's | 3 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lopez, RA; Slomiany, A; Slomiany, BL | 1 |
| Liau, YH; Lopez, RA; Slomiany, A; Slomiany, BL | 1 |
| Higo, K; Lee, MK; Miles, PD; Olefsky, JM; Rafaat, K; Romeo, OM | 1 |
| Hattori, J; Kawachi, S; Nakashima, K; Okumura, S; Sasaki, A; Sugimoto, M; Takami, K; Takami, R; Takeda, N; Yasuda, K; Yoshino, K | 1 |
| Riddle, MC | 1 |
| Laws, A | 1 |
| Weissman, P | 1 |
| Chawla, S; Takiya, L | 1 |
| Bonneau, NH; Desnoyers, M; Dupuis, J; Moreau, M | 1 |
| Fischer, S; Hanefeld, M | 1 |
| Beauchamp, G; Dupuis, J; Moreau, M; Paradis, M; Refsal, KR; Sauvé, F | 1 |
| Aragon, CL; Budsberg, SC; Hofmeister, EH | 1 |
| Abdo, M; Ajayi, K; Emge, TJ; Hanover, JA; Huhn, RA; Kim, EJ; Knapp, S | 1 |
| Amorelli, B; Knapp, S; Rempel, B; Withers, SG; Yang, C | 1 |
| Abdo, M; Emge, TJ; Fash, D; Knapp, S; Rablen, PR | 1 |
| Abdo, M; Darout, E; Hanover, JA; Kim, EJ; Knapp, S; Love, DC; Rablen, PR; Rempel, B; Withers, SG | 1 |
| Bennett, D; Chase, D; Parkin, T; Sul, RM | 1 |
| Benavides, GA; Chatham, JC; Cofield, SS; Darley-Usmar, V; Ouyang, X; Redmann, M; Shacka, JJ; Wani, WY; Zhang, J | 1 |
4 review(s) available for thiazoles and glucosamine
| Article | Year |
|---|---|
Oral pharmacologic management of type 2 diabetes.
Topics: 1-Deoxynojirimycin; Acarbose; Administration, Oral; Blood Glucose; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Enzyme Inhibitors; Glucosamine; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Imino Pyranoses; Metformin; Sulfonylurea Compounds; Thiazoles; Thiazolidinediones; United States | 1999 |
Reappraisal of the pharmacologic approach to treatment of type 2 diabetes mellitus.
Topics: Administration, Oral; Antihypertensive Agents; Biguanides; Diabetes Mellitus, Type 2; Glucosamine; Hormone Replacement Therapy; Humans; Hypoglycemic Agents; Hypolipidemic Agents; Insulin; Insulin Resistance; Sulfonylurea Compounds; Thiazoles | 2002 |
Therapeutic options for the management of type 2 diabetes mellitus.
Topics: 1-Deoxynojirimycin; Adult; Diabetes Mellitus, Type 2; Disease Management; Education, Medical, Continuing; Education, Pharmacy, Continuing; Glucosamine; Humans; Hypoglycemic Agents; Imino Pyranoses; Insulin; Insulin Aspart; Managed Care Programs; Metformin; Thiazoles; Thiazolidinediones; United States | 2002 |
Systematic review of clinical trials of treatments for osteoarthritis in dogs.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Chondroitin; Clinical Trials as Topic; Dog Diseases; Dogs; Evidence-Based Medicine; Glucosamine; Meloxicam; Osteoarthritis; Severity of Illness Index; Thiazines; Thiazoles; Treatment Outcome | 2007 |
2 trial(s) available for thiazoles and glucosamine
| Article | Year |
|---|---|
Clinical evaluation of a nutraceutical, carprofen and meloxicam for the treatment of dogs with osteoarthritis.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Ascorbic Acid; Carbazoles; Chondroitin Sulfates; Chronic Disease; Dog Diseases; Dogs; Double-Blind Method; Gait; Glucosamine; Lameness, Animal; Manganese Compounds; Meloxicam; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Prospective Studies; Severity of Illness Index; Stifle; Thiazines; Thiazoles; Treatment Outcome | 2003 |
Comparison of meloxicam and a glucosamine-chondroitin supplement in management of feline osteoarthritis. A double-blind randomised, placebo-controlled, prospective trial.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cat Diseases; Cats; Chondroitin; Dietary Supplements; Female; Glucosamine; Male; Meloxicam; Osteoarthritis; Thiazines; Thiazoles | 2014 |
12 other study(ies) available for thiazoles and glucosamine
| Article | Year |
|---|---|
Synthesis and secretion of gastric sulfomucin in the presence of ebrotidine, a new antiulcer agent.
Topics: Animals; Anti-Ulcer Agents; Benzenesulfonates; Dose-Response Relationship, Drug; Gastric Mucosa; Glucosamine; Glycosylation; Kinetics; Mucins; Proline; Rats; Sulfates; Thiazoles | 1992 |
Effect of ebrotidine on the synthesis and secretion of gastric sulfomucin.
Topics: Animals; Anti-Ulcer Agents; Benzenesulfonates; Gastric Mucosa; Glucosamine; Glycoproteins; In Vitro Techniques; Mucins; Proline; Rats; Sulfates; Sulfur Radioisotopes; Thiazoles | 1993 |
Troglitazone prevents hyperglycemia-induced but not glucosamine-induced insulin resistance.
Topics: Administration, Oral; Animals; Blood Glucose; Chromans; Cohort Studies; Glucosamine; Glucose Clamp Technique; Hormone Antagonists; Hypoglycemic Agents; Infusion Pumps; Insulin Resistance; Male; Rats; Rats, Sprague-Dawley; Somatostatin; Thiazoles; Thiazolidinediones; Troglitazone | 1998 |
Differential effects of troglitazone and D-chiroinositol on glucosamine-induced insulin resistance in vivo in rats.
Topics: Animals; Chromans; Glucosamine; Glucose Clamp Technique; Hypoglycemic Agents; Inositol; Insulin Resistance; Male; Rats; Rats, Wistar; Thiazoles; Thiazolidinediones; Time Factors; Troglitazone | 1999 |
A new era in type 2 diabetes mellitus treatment?
Topics: 1-Deoxynojirimycin; Acarbose; Carbamates; Diabetes Mellitus, Type 2; Glucosamine; Humans; Hypoglycemic Agents; Imino Pyranoses; Multicenter Studies as Topic; Pioglitazone; Piperidines; Randomized Controlled Trials as Topic; Thiazoles; Thiazolidinediones | 2001 |
[Therapy decision based on the glucose triad. Drug treatment of type 2 diabetes].
Topics: 1-Deoxynojirimycin; Acarbose; Administration, Oral; Blood Glucose; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Fasting; Glucosamine; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Imino Pyranoses; Insulin; Insulin Resistance; Insulin Secretion; Metformin; Obesity; Pioglitazone; Risk Factors; Rosiglitazone; Sulfonylurea Compounds; Thiazoles; Thiazolidinediones; Time Factors | 2003 |
Effects of oral administration of meloxicam, carprofen, and a nutraceutical on thyroid function in dogs with osteoarthritis.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Autoantibodies; Carbazoles; Chondroitin Sulfates; Dog Diseases; Dogs; Female; Glucosamine; Longitudinal Studies; Male; Manganese Compounds; Meloxicam; Osteoarthritis; Random Allocation; Thiazines; Thiazoles; Thyroid Function Tests; Thyroid Gland; Thyrotropin; Thyroxine; Treatment Outcome | 2003 |
Tautomeric modification of GlcNAc-thiazoline.
Topics: beta-N-Acetylhexosaminidases; Crystallography, X-Ray; Enzyme Inhibitors; Free Radicals; Glucosamine; Hexosaminidases; Humans; Isomerism; Models, Molecular; Molecular Conformation; Structure-Activity Relationship; Thiazoles | 2007 |
N-Acetylhexosaminidase inhibitory properties of C-1 homologated GlcNAc- and GalNAc-thiazolines.
Topics: beta-N-Acetylhexosaminidases; Binding Sites; Carbohydrate Sequence; Carbon; Enzyme Inhibitors; Galactose; Glucosamine; Kinetics; Models, Chemical; Molecular Sequence Data; Piperidines; Substrate Specificity; Thiazoles | 2008 |
GlcNAc-Thiazoline conformations.
Topics: beta-N-Acetylhexosaminidases; Crystallography, X-Ray; Enzyme Inhibitors; Glucosamine; Magnetic Resonance Spectroscopy; Molecular Conformation; Thermodynamics; Thiazoles | 2009 |
OGA inhibition by GlcNAc-selenazoline.
Topics: 3T3-L1 Cells; Acetylglucosamine; Adipocytes; Amino Acid Sequence; Animals; beta-N-Acetylhexosaminidases; Cell Differentiation; Cell Line; Clostridium perfringens; Enzyme Inhibitors; Glucosamine; Glucose Transporter Type 4; Glycosylation; HeLa Cells; Humans; Insulin; Mice; Models, Molecular; Molecular Sequence Data; Molecular Structure; Sequence Alignment; Structure-Activity Relationship; Thiazoles | 2010 |
O-GlcNAc regulation of autophagy and α-synuclein homeostasis; implications for Parkinson's disease.
Topics: alpha-Synuclein; Animals; Autophagy; Cells, Cultured; Glucosamine; Glycosylation; Homeostasis; Humans; Models, Biological; Neurons; Parkinson Disease; Phosphorylation; Postmortem Changes; Proto-Oncogene Proteins c-akt; Pyrans; Rats, Sprague-Dawley; Signal Transduction; Sirolimus; Thiazoles; TOR Serine-Threonine Kinases | 2017 |